StemCells Inc. (STEM) Awarded New Patent; Using the Basics of Life to Improve Life
StemCells Inc. (Nasdaq: STEM) focuses on the discovery, development and commercialization of cell-based therapeutics to treat diseases afflicting the central nervous system (CNS) and liver. Stem-cell research has become more widely accepted as the public becomes more educated on research methods and purposes. StemCells Inc.’s programs target damaged or lost CNS and liver tissue as a result of disease or injury. Stem-cell research opens the door to a plethora of discoveries regarding the human body’s regenerative abilities, and how to better treat disease. StemCells Inc. today announced that the U.S. Patent and Trademark Office awarded the company patent number 7,381,561…